Editorial
Lung cancer screening moving forward
Annals of Translational Medicine
2016;
4
(8)
:149
(April 2016)
Review Article
Lung cancer epidemiology: contemporary and future challenges worldwide
Annals of Translational Medicine
2016;
4
(8)
:150
(April 2016)
Risk factors assessment and risk prediction models in lung cancer screening candidates
Annals of Translational Medicine
2016;
4
(8)
:151
(April 2016)
Implementation and organization of lung cancer screening
Annals of Translational Medicine
2016;
4
(8)
:152
(April 2016)
The importance of the regimen of screening in maximizing the benefit and minimizing the harms
Annals of Translational Medicine
2016;
4
(8)
:153
(April 2016)
Advancing and sharing the knowledge base of CT screening for lung cancer
Annals of Translational Medicine
2016;
4
(8)
:154
(April 2016)
2016 reflections on the favorable cost-benefit of lung cancer screening
Annals of Translational Medicine
2016;
4
(8)
:155
(April 2016)
Management of CT screen-detected lung nodule: the thoracic surgeon perspective
Annals of Translational Medicine
2016;
4
(8)
:156
(April 2016)
Smoking cessation and lung cancer screening
Annals of Translational Medicine
2016;
4
(8)
:157
(April 2016)
Biomarkers of risk to develop lung cancer in the new screening era
Annals of Translational Medicine
2016;
4
(8)
:158
(April 2016)
Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?
Annals of Translational Medicine
2016;
4
(8)
:159
(April 2016)
Lung cancer screening in patients with chronic obstructive pulmonary disease
Annals of Translational Medicine
2016;
4
(8)
:160
(April 2016)
Disclosure:
The focused issue“Lung Cancer Screening” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Witold Rzyman and James L. Mulshine served as the unpaid Guest Editors for the focused issue.
